In addition, daily oral semaglutide was found to be ranked as the best GLP-1R agonist to reduce cardiovascular death and death from any cause when indirectly compared with injectable semaglutide, liraglutide, lixisenatide, dulaglutide, albiglutide, exenatide and placebo ( Oral semaglutide is also likely to be more cost-effective than other existing GLP-1R agonists in the treatment of T2D patients (Hansen et al., 2020)
The three approved injection sites are the abdomen, thigh, and the back of your upper arm, and it is essential to rotate your site each week to maintain the medication's effectiveness and prevent skin issues
If you have any comorbid conditions such as hypertension, heart disease, high cholesterol levels, liver or kidney disease, and type 2 diabetes, inform your doctor
Individualized treatment for iron-deficiency anemia in adults